ArticleWorld journal of gastroenterology2023
Dose escalation of adalimumab as a strategy to overcome anti-drug antibodies: A case report of infantile-onset inflammatory bowel disease.
Silvana Ancona et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.